demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comers
COVID 19 hospitalizedCOVID 19 all comers
angiotensin receptor blockers (ARBs) Nouri-Vaskeh
losartan University of Minnesota

2 studies excluded by filtering options 0

5595 Duarte, 2020 113high risk of bias
6139 Dublin, 2020 0120selection pending